SEC Form 4 · accession 0001225208-15-019092
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy A. Pratt
Officer — EVP, GC & Chief Admin Officer
Period of report
Oct 1, 2015
Accepted (ET)
Oct 2, 2015 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 1, 2015 | M | 17,000 | $13.56 | A | 339,893 | D | |
| Common StockF2 | Oct 1, 2015 | S | 17,000 | $16.3331 | D | 322,893 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $13.56 | Oct 1, 2015 | M | 17,000 | D | — | May 1, 2018 | Common Stock | 17,000 | 188,761 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.33 to $16.34, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Grant to the reporting person of an option to purchase 205,761 shares of common stock vesting in four equal annual installments commencing on May 1, 2009, the first anniversary of the date of grant.